- Home
- BNGO vs DRIO Comparison
BNGO vs DRIO Comparison
Compare BNGO & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- DRIO
- Stock Information
- Founded
- BNGO 2003
- DRIO 2011
- Country
- BNGO United States
- DRIO United States
- Employees
- BNGO N/A
- DRIO N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- DRIO Medical/Dental Instruments
- Sector
- BNGO Industrials
- DRIO Health Care
- Exchange
- BNGO Nasdaq
- DRIO Nasdaq
- Market Cap
- BNGO 24.3M
- DRIO 25.1M
- IPO Year
- BNGO 2018
- DRIO N/A
- Fundamental
- Price
- BNGO $0.20
- DRIO $0.80
- Analyst Decision
- BNGO Hold
- DRIO Strong Buy
- Analyst Count
- BNGO 3
- DRIO 1
- Target Price
- BNGO $1.00
- DRIO $4.00
- AVG Volume (30 Days)
- BNGO 3.0M
- DRIO 169.0K
- Earning Date
- BNGO 11-13-2024
- DRIO 11-07-2024
- Dividend Yield
- BNGO N/A
- DRIO N/A
- EPS Growth
- BNGO N/A
- DRIO N/A
- EPS
- BNGO N/A
- DRIO N/A
- Revenue
- BNGO $33,334,000.00
- DRIO $23,052,000.00
- Revenue This Year
- BNGO N/A
- DRIO $34.56
- Revenue Next Year
- BNGO $6.18
- DRIO $39.35
- P/E Ratio
- BNGO N/A
- DRIO N/A
- Revenue Growth
- BNGO N/A
- DRIO N/A
- 52 Week Low
- BNGO $0.20
- DRIO $0.65
- 52 Week High
- BNGO $2.27
- DRIO $2.60
- Technical
- Relative Strength Index (RSI)
- BNGO 31.53
- DRIO 52.51
- Support Level
- BNGO $0.20
- DRIO $0.65
- Resistance Level
- BNGO $0.28
- DRIO $0.80
- Average True Range (ATR)
- BNGO 0.02
- DRIO 0.06
- MACD
- BNGO -0.00
- DRIO 0.01
- Stochastic Oscillator
- BNGO 0.00
- DRIO 83.33
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.